Skip Navigation
Skip to contents

ACC : Acute and Critical Care



Page Path
HOME > Acute Crit Care > Forthcoming articles > Article
Original Article
Alcohol use disorder in the intensive care unit; a highly morbid condition; chemical dependency discussions during admission improves outcomes
Kristin Colling1,2orcid, Alexandra K. Kraft2orcid, Melissa L. Harry3orcid

Published online: January 10, 2023
  • 4 Download

1Department of Trauma Surgery, St. Mary’s Medical Center-Essentia Health, Duluth, MN, USA

2Department of Surgery, University of Minnesota Medical School, Minneapolis MN, USA

3Essentia Institute of Rural Health, Duluth, MN, USA

Corresponding Author: Kristin Colling Department of Trauma Surgery, Saint Mary’s Medical Center-Essentia Health, 407 E 3rd St, Duluth, MN 55805, USA Tel: +1-218-786-4210 Fax: +1-218-786-4639 E-mail:
• Received: April 26, 2022   • Revised: September 22, 2022   • Accepted: September 23, 2022

Copyright © 2022 The Korean Society of Critical Care Medicine

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • Background
    Alcohol use disorders (AUD) are common in patients admitted to intensive care units (ICU) and increase the risk for worse outcomes. In this study, we describe factors associated with patient mortality after ICU admission and the effect of chemical dependency (CD) counseling on outcomes in the year following ICU admission.
  • Methods
    We retrospectively reviewed patient demographics, hospital data, and documentation of CD counseling by medical providers for all ICU patients with AUD admitted to our institution between January 2017 and March 2019. Primary outcomes were in-hospital and 1-year mortality.
  • Results
    Of the 527 patients with AUD requiring ICU care, median age was 56 years (range, 18–86). Both in-hospital (12%) and 1-year mortality rates (27%) were high. Rural patients, comorbidities, older age, need for mechanical ventilation, and complications were associated with increased risk of in-hospital and 1-year mortality. CD counseling was documented for 73% of patients, and 50% of these patients accepted alcohol treatment or resources prior to discharge. CD evaluation and acceptance was associated with a significantly decreased rate of readmission for liver or alcohol-related issues (36% vs. 58%; odds ratio [OR], 0.41; 95% confidence interval [CI], 0.27–0.61) and 1-year mortality (7% vs. 19.5%; OR, 0.32; 95% CI, 0.16–0.64). CD evaluation alone, regardless of patient acceptance, was associated with a significantly decreased 1-year post-discharge mortality rate (12% vs. 23%; OR, 0.44; 95% CI, 0.25–0.77).
  • Conclusions
    ICU patients with AUD had high in-hospital and 1-year mortality. CD evaluation, regardless of patient acceptance, was associated with a significant decrease in 1-year mortality.
▪ Alcohol use disorder associated with critical illness continues to be associated with high mortality rates in the hospital and in the year after admission.
▪ Providers caring for patients with alcohol use disorder should be aware of the increased risk of complications and mortality, to mitigate this risk when possible and guide goals of care discussions.
▪ Provider-initiated chemical dependency counseling during the index admission for their critical illness, was associated with decreased 1-year mortality rates and readmissions.

Alcohol is the most used drug in the United States, with 50% of the population reported using alcohol in the past month according to the 2020 National Survey on Drug Use and Health [1]. Alcohol is also the most abused drug. Of the 138 million current alcohol users in the United States, 61 million reported binge drinking in the past month and 28 million, or 10% of the population, met criteria for alcohol use disorder (AUD) in the past year [1]. Alcohol use and abuse is associated with numerous detrimental physical and mental health effects [2], and between 2011 and 2015, excessive drinking was responsible for 261 deaths per day [3]. Harmful alcohol use is the third leading cause of preventable death in the United States [4]. In addition, alcohol abuse and its consequences are costly. In 2006, the estimated hospital costs for treatment of alcohol-related issues exceeded $5 billion, but the total estimated economic cost of excessive drinking exceeded $220 billion [5].
Alcohol abuse impacts individuals’ perception of the problem and ability to obtain treatment when needed. The vast majority of individuals with substance abuse disorder do not feel that they need treatment, with only 2.5% of people with substance abuse disorder perceiving a need for treatment [1]. In trauma patients, a formal discussion with their medical providers about their alcohol use, screening for alcohol abuse, and a discussion of how their alcohol use contributed to their injury has been shown to significantly decrease recidivism in these patients for traumatic injury associated with alcohol use [6,7]. The acuity and direct correlation of the two problems (alcohol use and their injury) has been hypothesized to be a “teachable moment” with greater chance of initiation of change [8].
Alcohol abuse that leads to an intensive care unit (ICU) admission is another opportunity for medical providers to use the life-threatening medical problem to help patients with AUD recognize the issue and may be an impetus for seeking treatment or behavioral change. In this study, we describe the patient population admitted to a tertiary referral center ICU serving a large, rural area, including risk factors associated with worse outcomes in patients with AUD and evaluating the effect of chemical dependency (CD) referral and evaluation.
We performed a retrospective review of patients admitted to an ICU in our Level 1 Trauma Center located in Northern Minnesota, in the upper Midwest of the United States serving a large rural area between January 1, 2017 and March 31, 2019. Patients with documented AUD (alcoholism, alcohol dependence, and alcohol abuse) were included in the study group. All patient’s charts were reviewed to ensure that they had an alcohol use history consistent with an AUD. Patients with only social alcohol use and those who opted out of research with the healthcare system were excluded. In addition, patient chart and ICU stays were reviewed, and any patient that was admitted to the ICU only for monitoring and who did not require intensive care of for least 48 hours was excluded. Intensive care was defined as a need for continuous intravenous medications requiring at least hourly titration by an ICU nurse, mechanical ventilation, or evidence of at least one ICU treated organ failure. This study was reviewed, monitored, and approved by the Institutional Review Board of Essentia Institute of Rural Health, Duluth, MN, USA (No. EH20653). Patient consent was waived for this study.
After the study cohort was identified and electronically abstracted, manual chart review was performed for all patients by the first author (KC). All patient demographics, including age, sex recorded at birth, self-identified race, marital status, and insurance type were recorded. Current or former use of tobacco or other drugs of abuse was collected, as well as if the patient was still drinking alcohol prior to admission. ICU and hospital data were recorded for all patients, including primary reason for admission, hospital and ICU length of stay, use of mechanical ventilation or non-invasive ventilation, and complications that occurred during the hospital stay. Complications were included in analysis as a composite variable of any complication during the hospital admission, as well as by individual complication type (alcohol withdrawal, infection, septic shock, organ failure, acute respiratory distress syndrome, thrombotic complications or bleeding complications). ICU type was defined not by the physical location, but by the primary intensivist team (medical critical team or surgical/trauma critical care team). All critical care physicians at our hospital are board certified in critical care. Trauma ICU and surgical ICU were defined as cared for by the surgical/trauma critical care team and then patients’ reason for admission. If admitted due to injury, the patient was classified as trauma ICU. If not injured, they were defined as surgical ICU. Manual chart review was performed of all in-patient documentation by the medical provider for documented discussion of alcohol-related CD evaluation and counseling regarding the health and quality of life benefits of alcohol cessation. If CD evaluation and counseling was documented as being performed, the chart was then reviewed for documentation of patient acceptance of further support, referrals, or a verbal willingness to quit. This provider-initiated CD counseling was performed once the patient was recovering from their critical illness and most occurred outside of the ICU. In-hospital and 1-year mortality, and 6-month post-discharge readmissions due to alcohol abuse or its complications were also documented.
Statistical analysis was performed using IBM SPSS version 26.0 (IBM Corp., Armonk, NY, USA). Descriptive analysis was performed for the cohort, as well as comparing outcome variables. Primary outcome variables were in-hospital mortality, 1-year post-discharge mortality, and 6-month post-discharge readmission. Variables were compared using chi-square tests for categorical variables, and Mann-Whitney U-tests for continuous, non-normally distributed variables. Binary logistic regression was used for multi-variate analysis, which controlled for patient age, sex, and any variables associated with the outcome variable in univariate regression analyses. P-values of less than 0.05 were considered statistically significant.
During the study period, 649 patients were admitted to our ICU with a diagnosis associated with AUD, which accounted for 8% of ICU admissions during the time period. Upon chart review, 122 patients were excluded as they did not require ICU care or had an ICU length of stay less than 48 hours, leaving 527 patients in our cohort (Figure 1). Patient demographics are described in Table 1. There was a wide age range, from 18 to 86 years. Median age was 56 years. Seventy percent of patients were male, and the majority were Caucasian, followed by American Indian/Alaska native, Black, and Asian/Native Hawaiian/Pacific islander. Over a one third of patients were from rural localities, 80% had two or more comorbidities, and 46% had liver failure or cirrhosis diagnosed prior to their admission. Even with the high number of patients with existing liver failure/cirrhosis, most patients (88%) were still drinking just prior to their admission. Of the 241 patients with liver failure/cirrhosis diagnosed prior to admission, 40% were still drinking.
The primary reason for admission varied as depicted in Figure 2. ICU care was performed in medical ICUs three-quarters of the time, followed by trauma then surgical ICU. The median ICU length of stay was 3 days, and the median hospital length of stay was 8 days. Most patients had at least one complication during their hospital stay (81%) (Figure 3). The most common complications were symptomatic alcohol withdrawal, infections, and bleeding. Compared to patients who did not have complications, patients with complications had significantly longer hospital stays (median: 9 days; interquartile range [IQR]: 5–14 vs. 4 days [2–7]) and ICU stays (median [IQR]: 4 days [2–7] vs. 2 days [2–3]). Approximately half of patients were discharged to home, followed by discharge to skilled nursing or acute rehab. Nine percent were discharged to inpatient mental health treatment and 12% of patients died during their hospital stay. In our cohort of ICU patients with severe AUD, almost one third died within a year of ICU admission based on available mortality data.
Table 2 depicts patient and hospital variables and their association with in-hospital mortality and 1-year mortality. Patients who died in the hospital were significantly older (median age [IQR]: 59 years [50–67] vs. 55 years [44–63]; P=0.008). Patients who died in the hospital also had longer ICU stays (median age [IQR]: 6 days [3–10] vs. 3 days [2–5]; P<0.001). There was no statistically significant difference in total hospital length of stay.
To better clarify independent risk factors associated with in-hospital mortality, a binary logistic regression was performed controlling for patient age, sex, number of comorbidities, and including risk factors for inpatient mortality identified as statistically significant in univariate regression analyses (rurality, cirrhosis or liver failure prior to admission, need for mechanical ventilation, and in-hospital complications). Figure 4 details the adjusted odds ratio (OR) and 95% confidence interval (CI) for each variable in this model. There was an independently associated increased risk of death for each additional comorbidity, liver failure and respiratory failure. The model had a Hosmer and Lemeshow test P-value of 0.97. For patients with pre-existing liver failure or cirrhosis, in-hospital mortality was significantly higher for Child-Pugh class C (A=15%, B=14%, C=37%; P<0.001). Model for end-stage liver disease (MELD) scores for patients that died were significantly higher than those that survived their hospital stay (median [IQR]: 26 [15–34] vs. 8 [12–24]; P<0.001).
Mortality within 1 year of ICU admission was high, with 27% of all patients admitted to the ICU with AUD dying within 1 year. Sixty-three patients died in the hospital, and 81 patients of the 464 patients who survived discharge died in the year after admission. One-year mortality rates were higher in females, older patients, and rural patients (Table 2). Increased number of comorbidities was also associated with higher rates of 1-year mortality. Patients with pre-existing liver disease or cirrhosis had a 1-year mortality rate of 47%. In patients with liver failure prior to admission, patients with a Child-Pugh Score C had a 65% 1-year mortality rate, compared to Child-Pugh scores of A or B (35%, P<0.001). MELD score was also associated with risk of 1-year mortality (median [IQR]: 1-year mortality group, 23 [16–30] vs. survivor, 17 [12–23]; P<0.001).
In addition to high risk of mortality, our cohort had a high readmission rate within 6 months of their index ICU admission (Table 3). Of the 464 patients that survived to discharge after their ICU admission, 48% were readmitted. Although most of our cohort was male, females were significantly more likely to be readmitted. Patient with liver failure/cirrhosis diagnosed prior to their ICU admission (OR,1.99; 95% CI, 1.37–2.91) had significantly higher odds of being readmitted. Patients that were readmitted had significantly higher odds of dying within the year after their ICU admission compared to those who were not readmitted (OR, 2.68; 95% CI, 1.60–4.50).
Effects of Provider-Initiated CD Discussions
To evaluate the effect of provider-initiated CD discussion regarding their alcohol abuse and its effect on their health, we evaluated the subset of patients in our cohort who were still drinking prior to admission and survived to discharge. Sixty-four patients had complete alcohol cessation prior to admission and 103 patients died in the hospital, leaving 414 patients in this subgroup analysis. A total of 303 patients (73%) had a documented CD discussion by a provider. Table 4 describes the patient and hospital-level factors associated with CD evaluation. Older patients, as well as those with Medicare insurance, longer hospital stays, admissions with sepsis, and with more comorbidities were less likely to have a CD evaluation during their stay. Hospital length of stay was longer in patients that did not receive CD evaluation, but ICU stay was not different and there was no significant difference in the rate of complications. Of the 303 patients that received CD evaluation, 153 (50%) accepted CD support and information on alcohol cessation and voiced a desire to quit. CD evaluation and acceptance was associated with a significantly decreased rates of readmission for liver or alcohol related issues (36% vs. 58%; OR, 0.41; 95% CI, 0.27–0.61) and significantly decreased rates of 1-year mortality (7% vs. 19.5%; OR, 0.32; 95% CI, 0.16–0.64). CD evaluation alone, regardless of patient acceptance, was associated with a nonsignificant decreased rate and odds of readmission for alcohol or liver issues in the next 6 months (48% vs. 57%; OR, 0.68; 95% CI, 0.43–1.05), and with a significantly decreased rate in mortality 1-year after admission (12% vs. 23%; OR, 0.44; 95% CI, 0.25–0.77).
In this large, retrospective cohort study based in a predominately rural area of the Upper Midwest of the United States, we found that ICU admission in patients with alcohol abuse is common and associated with high morbidity and mortality. Alcohol abuse was identified in approximately 8% of ICU admissions at our hospital, which is similar to other studies, where alcohol abuse has been associated with 7%–34% of ICU admission [9-15]. Death during the index hospitalization was common, with 12% of patients dying during their hospital stay. This is similar to other studies that have evaluated alcohol dependence or abuse in ICU patients, which have reported mortality rates between 9%–30% [9-16]. In addition to high mortality in the hospital, we found these patients are at significant risk for death within a year of their admission. Specifically, 27% of the patients in our study died within a year of their admission. Christensen et al. reported that patients admitted to the ICU for issues related to alcohol abuse with any chronic complications had an increased risk of death that continued for 3 years after their initial admission [17]. Patients with alcoholic liver disease or cirrhosis were at the highest risk of death in our study, with a 23% in-hospital mortality rate and a 47% 1-year mortality rate. Mortality rates for patients with liver cirrhosis admitted to the ICU have ranged from 18%–100% in other studies [18-26]. While in-hospital mortality has been decreasing in more recent studies to rates more in line with our findings, long-term mortality rates remain high for patients with liver disease who require ICU admission [24,27,28]. Improvements in supportive care can resolve the acute illness, but long-term treatments for liver failure are still lacking. Liver dysfunction has been associated with impaired immune functioning, higher risk of bleeding, increased rates and worse outcomes in acute respiratory distress syndrome, and changes in metabolism and nutrition, which may account for the increased risk of mortality in these patients during and after acute illness [29-35].
Other risk factors for increased mortality in patients with AUD in our study included increased comorbidities at time of admission, need for mechanical ventilation, complications during the hospital stay, and need for blood transfusions. These findings are similar to other risk factors for death in all patients needing ICU care. In addition, we found that rural patients had significantly increased rates of in-hospital and 1-year mortality when compared to non-rural patients. Alcohol use in rural communities varies by region; however, current AUD has a lower prevalence in suburban areas (11%) compared to urban areas (14%) and is highest in rural areas (15%) [36]. Rural patients also tend to have higher rates of comorbidities and may have less access to preventive health care. In our study, while men accounted for the majority of patients, female sex was associated with an increased risk of death within a year of ICU admission.
We found that in addition to the high risk of mortality, patients with alcohol abuse admitted to the ICU required significant resource utilization. ICU and hospital lengths of stay were long, and 80% of patients had a complication during their hospital stay, and the vast majority required intubation during their stay, leading to high resource utilization in this patient group. Cervellione et al. [37] evaluated ICU resource utilization in patients with drug and alcohol abuse and reported similar hospital and ICU lengths of stay (median: hospital length of stay, 6 days; ICU length of stay, 3 days). They also found that the median cost per day was approximately $5,000 [34]. In addition to the resource utilization during the index admission, almost half of the patients in our study’s cohort were readmitted due to alcohol related issues in the 6 months after discharge. This number is likely an underestimate of the true rate of readmission, as patients may have presented to an outlying hospital whose data would not be available to this study.
Theoretically, most, if not all ICU admissions associated with AUD described in this study are preventable. If patients can decrease or cease alcohol use, overall population health could be significantly improved, and hospital costs could be decreased. In our study, we found that provider-led CD counseling and treatment discussions were associated with significant reductions in the rates of readmission and subsequent mortality. Using these high-risk situations as opportunities for employing motivational interviewing techniques to assist patients with changing their alcohol use, and hopefully setting up treatment options, has been described by other groups [8,38,39]. Importantly, in the present study, we found that even when patients did not voice acceptance of treatment support or a willingness to change, the CD counseling received was still associated with a decrease in 1-year mortality and a nonsignificant trend toward lower readmission rates. We feel that every opportunity for motivational change and active discussion with patients is important as even if they are not willing to change at the time of initial discussion, it may lay important groundwork for subsequent opportunities. Clark et al. [40] found that for patient with unhealthy alcohol use admitted to the ICU, the severity of acute illness was significantly associated with a readiness to change. Providers need to continue to support patients and advocate for healthy behavior modifications.
We found that there are opportunities for improving the rates of CD counseling offered by providers, possibly indicative of provider biases that led them to not provide counseling where it may have been valuable for patients. For example, older patients were less likely to have CD counseling during their stay. It is possible that providers felt that alcohol use in older patients is more deeply embedded and less likely to be amendable to habit change; however, this is a missed opportunity for intervention. In addition, patients admitted for treatment of sepsis or infection were less likely to have alcohol CD counseling. Patients admitted with alcohol intoxication, overdose, or withdrawal had high rates of CD counseling documented, including rates that were higher than in patients with AUD who did not have an AUD diagnosis directly attached to the admission etiology. This highlights the need for greater provider awareness and use of alcohol use and abuse screening for patients without alcohol-related admission diagnoses. In addition, active and standardized approaches to inpatient alcohol screening and counseling have been associated with improved rates of identifying patients at risk and improving outcomes [6,7]. This may be evidenced in our high rate of alcohol CD counseling in our trauma patients, where screening and brief interventions have been standardized and have high rates of use [41], particularly compared to other hospital admitting services. Currently, other ICU services do not have standard protocol for who should receive CD counselling, it is left to provider discretion. While the present study did not identify significant race or gender disparities, other studies have noted disparities in access to substance abuse treatment and screening based on race and gender, and providers should be cognizant of possible implicit biases [42]. Standardization of alcohol use screening and CD counseling across all care groups may help decrease these disparities.
Access to treatment for alcohol disorders remains an issue in the United States. In a 2020 national survey, numerous barriers to receiving treatment were identified [1]. The most common reason, reported by 19% of patients, was a lack of health care coverage and not being able to afford treatment [1]. Stigma regarding alcohol abuse may also be an ongoing hinderance to receiving alcohol use treatment when needed, with 12% reporting that they felt that receiving treatment for their alcohol issues would cause their neighbors or community members to have a negative opinion about them [1]. Medical providers discussing alcohol abuse and its consequences may help patients feel supported in requesting treatment and decrease stigma, assisting patients and families with viewing AUDs as treatable medical conditions, not individual failings or weaknesses.
We added to the literature on the high risks associated with alcohol abuse and critical illness through our focus in this study on a mainly rural population, as well as by limiting the retrospective review to those patients receiving ICU care for organ dysfunction. By removing patients who were only monitored in the ICU, we described those patients with critical illness associated with alcohol abuse and AUD. The study is limited by its single center design, as well as the use of retrospective data. Due to the limitations of the available data, we did not use an alcohol use screening tool to identify and quantify the severity of alcohol abuse and instead used diagnoses entered into the medical record to identify our cohort, which may have missed patients who qualified. We were also unable to grade alcohol abuse based on amount of alcohol used by patient report. In addition, mortality may have been higher, as our access to mortality data for the study cohort was limited to mortality data available in the medical record.
ICU patients with alcohol abuse and AUD continue to have high rates of in-hospital mortality, as well as ongoing risk of death in the year following index admission. These patients accounted for high ICU and hospital resource use and had high rates of readmissions. Provider-led CD counseling can be associated with significant improvements in patient outcomes, and ongoing efforts to increase rates of in-hospital alcohol use screening and interventions to provide treatment options are imperative.


No potential conflict of interest relevant to this article was reported.




Conceptualization: KPC, MLH. Data curation: KPC, AKK. Formal analysis: all authors. Methodology: KPC, MLH. Project administration: KPC. Visualization: KPC, MLH. Writing–original draft: KPC. Writing–review & editing: all authors.

Figure 1.
Flowchart of patient inclusion and exclusion.
Figure 2.
Primary reason for admission to the intensive care unit for patients with alcohol use disorder or alcoholic liver failure. GI: gastrointestinal.
Figure 3.
Complications during the hospital stay in patients with alcohol use disorder or alcoholic liver failure. In-hospital complications is reported as a composite variable (any patient that had one or more of the subcategories of complications listed) and as individual complications. ARDS: acute respiratory distress syndrome.
Figure 4.
Forest plot depicting the adjusted odds ratio (OR) for in-hospital mortality and patient or hospital-stay associated factors using logistic regression. Comorbidities, liver failure, and need for mechanical ventilation were independently associated with risk of in-hospital death. CI: confidence interval.
Table 1.
Patient demographics for all patients with alcohol abuse admitted for intensive care
Variable No. of patients (%) (n=527)
Age (yr)a) 56 (18–86)
Age <65 yr 121 (23)
 Female 160 (30)
 Male 367 (70)
 White 418 (79)
 Black 11 (2)
 American Indian/Alaska native 88 (17)
 Asian/Hawaiian/Pacific islander 6 (1)
 Unknown 4 (0.7)
Rural 189 (36)
 Uninsured 115 (21)
 Private 71 (14)
 Medicare 156 (29)
 Medicaid 185 (36)
 Liver failure 241 (46)
 Diabetes mellitus 111 (21)
 Cancer 52 (10)
 Chronic renal disease 85 (16)
 Cardiac disease 311 (60)
 Chronic respiratory disease 154 (29)
 Thrombocytopenia 194 (37)
 Mental health diagnosis 307 (58)
Two or more comorbidities 424 (80)
Still drinking prior to admission 463 (88)
Tobacco useb)
 Current 322 (61)
 Former 121 (23)
 Never 83 (16)
Other drug useb)
 Current 100 (19)
 Former 23 (4)
 Never 401 (77)
ICU care type
 Medical ICU 396 (75)
 Trauma ICU 89 (17)
 Surgical ICU 42 (8)
Intubated during admission 263 (50)
Blood transfused during admission 115 (22)
ICU length of stay (day)c) 3 (2–6)
Hospital length of stay (day)c) 8 (4–13)
Complication during hospital stay 428 (81)
Discharge dispositionb)
 Home 267 (51)
 Skilled nursing 72 (14)
 Acute rehab 36 (7)
 Inpatient mental health treatment 46 (9)
 Other hospital 6 (1)
 Against medical advice 15 (3)
 Hospice 20 (4)
In-hospital mortality 63 (12)
1-Year mortality 144 (27)
6-Month readmission for alcohol or liver related issue 239 (48)

ICU: intensive care unit.

a) Median (range);

b) Some values were missing for these variables;

c) Median (interquartile range).

Table 2.
Mortality rate by patient and hospital stay variables
Variable In-hospital mortality (%)a) P-value 1-Year mortality (%)b) P-value
Female 14 0.26 33 0.05
Age ≥65 yr 16 0.14 39 <0.001
Race 0.64 0.81
 White 12 27
 Black 0 18
 American Indian/Alaska native 11 30
 Asian/Hawaiian/Pacific islander 10 20
 Unknown 0 0
Rural 16 0.04 35 0.01
Insurance status 0.02 <0.001
 Uninsured 9 30
 Private insurance 7 16
 Medicare 19 38
 Medicaid 10 21
 Liver failure 23 <0.001 47 <0.001
 Diabetes mellitus 15 0.22 36 0.02
 Cancer 23 0.01 52 <0.001
 Chronic renal disease 24 <0.001 45 <0.001
 Cardiac disease 15 0.01 32 0.01
 Chronic respiratory disease 19 0.01 39 <0.001
 Thrombocytopenia 22 <0.001 40 <0.001
 Mental health diagnosis 14 0.15 27 0.86
Two or more comorbidities 15 <0.001 32 <0.001
Still drinking 11 0.01 24 <0.001
Current tobacco use 12 0.99 26 0.43
ICU type 0.52 0.01
 Medical 13 30
 Surgical 10 29
 Neurotrauma 9 15
Mechanical ventilation 21 <0.001 32 0.02
Complication in the Hospital 15 <0.001 31 <0.001
Alcohol withdrawal 9 0.01 21 <0.001
Septic shock 38 <0.001 55 <0.001
Cardiac complication 36 <0.001 52 <0.001
Renal failure 34 <0.001 55 <0.001
ARDS 49 <0.001 69 <0.001
Thrombosis 19 0.02 47 0.04
Received blood transfusion 17 0.04 37 0.01

ICU: intensive care unit; ARDS: acute respiratory distress syndrome.

a) n=63 (12%);

b) n=144 (27%).

Table 3.
Patient and hospitalization variables associated with 6-month readmissions related to alcohol use
Variable 6-Month readmission rate (%)a) P-value
Female 58 0.04
Age ≥65 yr 46 0.25
Self-reported race 0.47
 White 49
 Black 64
 American Indian/Alaska native 58
 Asian/Pacific islander 56
Rural 48 0.31
Insurance status <0.001
 Uninsured 67
 Private insurance 36
 Medicare 53
 Medicaid 46
 Diabetes 45 0.16
 Chronic renal disease 60 0.15
 Cancer 53 0.85
 Cardiac disease 52 0.76
 Chronic respiratory disease 50 0.70
 Thrombocytopenia 51 0.31
 Mental health disorder 52 0.62
 Cirrhosis/liver failure 61 <0.001
Two or more comorbidities 53 0.10
Still drinking prior to admission 50 0.18
Current tobacco use 50 0.78
Intubated during hospital stay 44 0.01
Complication in the hospital 55 0.01
Alcohol withdrawal 54 0.59
Septic shock 41 0.12
Cardiac complication 47 0.55
Renal failure 57 0.31
ARDS 39 0.19
Thrombotic complication 62 0.22
Received blood transfusion 59 0.09

ARDS: acute respiratory distress syndrome.

a) n=239 (48%).

Table 4.
Patient and admission variables associated with alcohol chemical dependency counseling
Variable All patients (n=414) CD evaluation (n= 303) No CD evaluation (n=111) P-value
Agea) (yr) 54 (18–83) 51 (18–76) 60 (27–83) <0.001
Female 120 (29) 85 (28) 35 (32) 0.49
Race 0.52
 White 324 (78) 240 (79) 84 (76)
 Black 11 (3) 6 (2) 5 (5)
 American Indian/Alaska native 50 (17) 50 (17) 20 (18)
Rural 138 (33) 99 (33) 39 (35) 0.64
Insurance <0.001
  Uninsured 78 (20) 62 (22) 16 (15)
 Private 62 (15) 52 (18) 10 (9)
 Medicare 100 (25) 57 (19) 43 (40)
 Medicaid 157 (39) 118 (41) 39 (36)
ICU length of stayb) (day) 3 (2–5) 3 (2–5) 3 (2–8) 0.24
Hospital length of stayb) (day) 8 (4–13) 7 (4–12) 9 (5–17) 0.01
 Diabetes mellitus 78 (18) 48 (16) 28 (25) 0.03
 Chronic renal disease 46 (11) 23 (8) 23 (21) <0.001
 Cancer 28 (7) 16 (5) 12 (11) 0.05
 Cirrhosis 73 (25) 55 (26) 18 (22) 0.50
 Cardiac disease 230 (56) 146 (48) 84 (76) <0.001
 Chronic respiratory disease 109 (26) 62 (21) 47 (42) <0.001
 Thrombocytopenia 119 (29) 79 (26) 40 (36) 0.05
 Psychiatric diagnosis 245 (59) 185 (61) 60 (54) 0.20
Reason for admission
 Acute intoxication 33 (8) 31 (10) 2 (2) 0.01
 Alcohol withdrawal 62 (15) 53 (18) 9 (8) 0.02
 Traumatic injury 77 (19) 68 (22) 9 (8) 0.01
 Sepsis/infection 41 (10) 24 (8) 17 (15) 0.03
 Suicide/overdose 36 (9) 33 (11) 3 (3) 0.01
Complication during admission 283 (68) 204 (67) 79 (71) 0.46
Readmission for alcohol/liver issue within 6 months 207 (50) 144 (48) 63 (57) 0.08
1-Year mortality 62 (15) 36 (12) 26 (23) 0.01

Values are presented as number (%) unless otherwise indicated.

a) Median (range);

b) Median (interquartile range).

  • 1. Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2020 national survey on drug use and health. Rockville, MA, Substance Abuse and Mental Health Services Administration. 2020.
  • 2. Rehm J, Gmel GE Sr, Gmel G, Hasan OS, Imtiaz S, Popova S, et al. The relationship between different dimensions of alcohol use and the burden of disease-an update. Addiction 2017;112:968-1001.ArticlePubMedPMCPDF
  • 3. Esser MB, Sherk A, Liu Y, Naimi TS, Stockwell T, Stahre M, et al. Deaths and years of potential life lost from excessive alcohol use: United States, 2011-2015. MMWR Morb Mortal Wkly Rep 2020;69:1428-33.ArticlePubMedPMC
  • 4. National Institute on Alcohol Abuse and Alcoholism (NIAAA). Alcohol facts and statistics [Internet]. Bethesda (MD), NIAAA. 2019;[cited 2022 Feb 18]. Available from:
  • 5. Bouchery EE, Harwood HJ, Sacks JJ, Simon CJ, Brewer RD. Economic costs of excessive alcohol consumption in the U.S., 2006. Am J Prev Med 2011;41:516-24.ArticlePubMed
  • 6. Longabaugh R, Woolard RE, Nirenberg TD, Minugh AP, Becker B, Clifford PR, et al. Evaluating the effects of a brief motivational intervention for injured drinkers in the emergency department. J Stud Alcohol 2001;62:806-16.ArticlePubMed
  • 7. Cordovilla-Guardia S, Fernández-Mondéjar E, Vilar-López R, Navas JF, Portillo-Santamaría M, Rico-Martín S, et al. Effect of a brief intervention for alcohol and illicit drug use on trauma recidivism in a cohort of trauma patients. PLoS One 2017;12:e0182441.ArticlePubMedPMC
  • 8. Clark BJ, Moss M. Secondary prevention in the intensive care unit: does intensive care unit admission represent a “teachable moment?”. Crit Care Med 2011;39:1500-6.ArticlePubMedPMC
  • 9. Uusaro A, Parviainen I, Tenhunen JJ, Ruokonen E. The proportion of intensive care unit admissions related to alcohol use: a prospective cohort study. Acta Anaesthesiol Scand 2005;49:1236-40.ArticlePubMed
  • 10. O’Brien JM Jr, Lu B, Ali NA, Martin GS, Aberegg SK, Marsh CB, et al. Alcohol dependence is independently associated with sepsis, septic shock, and hospital mortality among adult intensive care unit patients. Crit Care Med 2007;35:345-50.ArticlePubMed
  • 11. McKenny M, O’Beirne S, Fagan C, O’Connell M. Alcohol-related admissions to an intensive care unit in Dublin. Ir J Med Sci 2010;179:405-8.ArticlePubMedPDF
  • 12. Geary T, O’Brien P, Ramsay S, Cook B, Scottish Intensive Care Trainees’ Audit Share Group. A national service evaluation of the impact of alcohol on admissions to Scottish intensive care units. Anaesthesia 2012;67:1132-7.ArticlePubMed
  • 13. Gacouin A, Tadie JM, Uhel F, Sauvadet E, Fillâtre P, Letheulle J, et al. At-risk drinking is independently associated with ICU and one-year mortality in critically ill nontrauma patients. Crit Care Med 2014;42:860-7.ArticlePubMed
  • 14. Lynch C, Pugh R, Battle C, Welsh Intensive Care Society Audit and Research Group (WICSARG). A multicentre prospective evaluation of alcohol-related admissions to intensive care units in Wales. J Intensive Care Soc 2017;18:193-7.ArticlePubMedPMCPDF
  • 15. McPeake JM, Shaw M, O’Neill A, Forrest E, Puxty A, Quasim T, et al. Do alcohol use disorders impact on long term outcomes from intensive care? Crit Care 2015;19:185. ArticlePubMedPMCPDF
  • 16. Trainor D, Martin L, Lavery G. Alcohol misuse requiring admission to a tertiary referral ICU: resource implications. Crit Care 2009;13:1-2.Article
  • 17. Christensen S, Johansen MB, Pedersen L, Jensen R, Larsen KM, Larsson A, et al. Three-year mortality among alcoholic patients after intensive care: a population-based cohort study. Crit Care 2012;16:R5. ArticlePubMedPMC
  • 18. Mackle IJ, Swann DG, Cook B. One year outcome of intensive care patients with decompensated alcoholic liver disease. Br J Anaesth 2006;97:496-8.ArticlePubMed
  • 19. Heydtmann M, McDonald SA. Survival and re-admission of patients admitted with alcoholic liver disease to a West of Scotland hospital. Scott Med J 2013;58:134-8.ArticlePubMedPDF
  • 20. Kavli M, Strøm T, Carlsson M, Dahler-Eriksen B, Toft P. The outcome of critical illness in decompensated alcoholic liver cirrhosis. Acta Anaesthesiol Scand 2012;56:987-94.ArticlePubMed
  • 21. Aggarwal A, Ong JP, Younossi ZM, Nelson DR, Hoffman-Hogg L, Arroliga AC. Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU. Chest 2001;119:1489-97.ArticlePubMed
  • 22. Goldfarb G, Nouel O, Poynard T, Rueff B. Efficiency of respiratory assistance in cirrhotic patients with liver failure. Intensive Care Med 1983;9:271-3.ArticlePubMedPDF
  • 23. Levesque E, Saliba F, Ichaï P, Samuel D. Outcome of patients with cirrhosis requiring mechanical ventilation in ICU. J Hepatol 2014;60:570-8.ArticlePubMed
  • 24. Baudry T, Hernu R, Valleix B, Jahandiez V, Faucher E, Simon M, et al. Cirrhotic patients admitted to the ICU with septic shock: factors predicting short and long-term outcome. Shock 2019;52:408-13.ArticlePubMed
  • 25. Lai CC, Tseng KL, Ho CH, Chiang SR, Chan KS, Chao CM, et al. Outcome of liver cirrhosis patients requiring prolonged mechanical ventilation. Sci Rep 2020;10:4980. ArticlePubMedPMCPDF
  • 26. McPhail MJ, Parrott F, Wendon JA, Harrison DA, Rowan KA, Bernal W. Incidence and outcomes for patients with cirrhosis admitted to the United Kingdom critical care units. Crit Care Med 2018;46:705-12.ArticlePubMedPMC
  • 27. Gildea TR, Cook WC, Nelson DR, Aggarwal A, Carey W, Younossi ZM, et al. Predictors of long-term mortality in patients with cirrhosis of the liver admitted to a medical ICU. Chest 2004;126:1598-603.ArticlePubMed
  • 28. Huang YF, Lin CS, Cherng YG, Yeh CC, Chen RJ, Chen TL, et al. A population-based cohort study of mortality of intensive care unit patients with liver cirrhosis. BMC Gastroenterol 2020;20:15. ArticlePubMedPMCPDF
  • 29. Patidar KR, Peng JL, Kaur H, Worden A, Kettler CD, Pike F, et al. Severe alcohol-associated hepatitis is associated with worse survival in critically ill patients with acute on chronic liver failure. Hepatol Commun 2022;6:1090-9.ArticlePubMedPDF
  • 30. Horvatits T, Drolz A, Trauner M, Fuhrmann V. Liver injury and failure in critical illness. Hepatology 2019;70:2204-15.ArticlePubMedPDF
  • 31. Albillos A, Lario M, Álvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol 2014;61:1385-96.ArticlePubMed
  • 32. Flores B, Trivedi HD, Robson SC, Bonder A. Hemostasis, bleeding and thrombosis in liver disease. J Transl Sci 2017;3:10.15761/JTS.1000182.ArticlePubMedPMC
  • 33. Boente RD, Sheikh A, Bosslet GT, Ghabril MS. Outcomes of acute respiratory distress syndrome in mechanically ventilated patients with cirrhosis. Crit Care Explor 2019;1:e0040.ArticlePubMedPMC
  • 34. Herrero R, Sánchez G, Asensio I, López E, Ferruelo A, Vaquero J, et al. Liver-lung interactions in acute respiratory distress syndrome. Intensive Care Med Exp 2020;8(Suppl 1):48. ArticlePubMedPMCPDF
  • 35. Stirnimann J, Stirnimann G. Nutritional challenges in patients with advanced liver cirrhosis. J Clin Med 2019;8:1926. ArticlePubMedPMC
  • 36. Borders TF, Booth BM. Rural, suburban, and urban variations in alcohol consumption in the United States: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. J Rural Health 2007;23:314-21.ArticlePubMed
  • 37. Cervellione KL, Shah A, Patel MC, Curiel Duran L, Ullah T, Thurm C. Alcohol and drug abuse resource utilization in the ICU. Subst Abuse 2019;13:1178221819869327. ArticlePubMedPMCPDF
  • 38. Clark BJ, Sorrell T, Hodapp RM, Reed K, Moss M, Aagaard L, et al. Pilot randomized trial of a recovery navigator program for survivors of critical illness with problematic alcohol use. Crit Care Explor 2019;1:e0051.ArticlePubMedPMC
  • 39. Schermer CR, Moyers TB, Miller WR, Bloomfield LA. Trauma center brief interventions for alcohol disorders decrease subsequent driving under the influence arrests. J Trauma 2006;60:29-34.ArticlePubMed
  • 40. Clark BJ, Smart A, House R, Douglas I, Burnham EL, Moss M. Severity of acute illness is associated with baseline readiness to change in medical intensive care unit patients with unhealthy alcohol use. Alcohol Clin Exp Res 2012;36:544-51.ArticlePubMed
  • 41. Harry ML, Lake E, Woehrle TA, Heger AM, Vogel LE. Implementing a screening and brief intervention protocol for excessive alcohol use in a trauma center: a healthcare improvement project. J Addict Nurs 2022;33:247-54.
  • 42. Tucker JA, Chandler SD, Witkiewitz K. Epidemiology of recovery from alcohol use disorder. Alcohol Res 2020;40:02. Article

Figure & Data



    Citations to this article as recorded by  

      We recommend

      ACC : Acute and Critical Care